Combined orchiectomy and external radiotherapy versus radiotherapy alone for nonmetastatic prostate cancer with or without pelvic lymph node involvement: A prospective randomized study

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 2030-2034

  Granfors, Torvald ^a   Modig, Hans ^a   Damber, Jan Erik ^a   Tomic, Radisa ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Neoplasm staging; Prognosis; Prostatic neoplasms; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CASTRATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORCHIECTOMY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; RANDOMIZED CONTROLLED TRIAL;

EID: 0032412702     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63235-X     Document Type: Article

References (20)

1. Walsh, P. C., Partin, A. W. and Epstein, J. I.: Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J. Urol., 152: 1831, 1994.
2. Hanks, G. E., Lee, W. R. and Schultheiss, T. E.: Clinical and biochemical evidence of control of prostate cancer at 5 years after external beam radiation. J. Urol., 154: 456, 1995.
3. Lawton, C. A., Glisch, C., Byhardt, R. W., Sehring, S., Hartz, A. and Cox, J. D.: Extended-field radiation therapy for prostatic carcinoma with para-aortic lymph node metastasis. Amer. J. Clin. Oncol., 9: 302, 1986.
4. Asbell, S. O., Krall, J. M., Pilepich, M. V., Baerwald, H., Sause, W. T., Hanks, G. E. and Perez, C. A.: Elective pelvic irradiation in stage A2, B carcinoma of the prostate: analysis of RTOG 77-06. Int. J. Rad. Oncol. Biol. Physiol., 15: 1307, 1988.
5. Gervasi, L. A., Mata, J., Easley, J. D., Wilbanks, J. H., Seale-Hawkins, C., Carlton, C. E., Jr. and Scardino, P. T.: Prognostic significance of lymph nodal metastases in prostate cancer. J. Urol., 142: 332, 1989.
6. Leibel, S. A., Zelefsky, M. J., Kutcher, G. J., Burman, C. M., Mohan, R., Mageras, G. S., Ling, C. C. and Fuks, Z.: The biological basis and clinical application of three-dimensional conformal external beam radiation therapy in carcinoma of the prostate. Sem. Oncol., 21: 580, 1994.
7. Zagars, G. K., Sands, M. E., Pollack, A. and von Eschenbach, A. C.: Early androgen ablation for stage D1 (N1 to N3, M0) prostate cancer: prognostic variables and outcome. J. Urol., 151: 1330, 1994.
8. Johansson, J.-E.: Expectant management of early stage prostatic cancer: Swedish experience. J. Urol., 152: 1753, 1994.
9. The Medical Research Council Prostate Cancer Working Party Investigators Group: Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council Trial. Brit. J. Urol., 79: 235, 1997.
10. Pilepich, M. V., Krall, J. M., Sause, W. T., Johnson, R. J., Russ, H. H., Hanks, G. E., Perez, C. A., Zinninger, M. and Martz, K. L.: Prognostic factors in carcinoma of the prostate analysis of RTOG study 75-06. Int. J. Rad. Oncol. Biol. Physiol., 13: 339, 1987.
11. Green, N., Bodner, H., Broth, E., Chiang, C., Garrett, J., Goldstein, A., Goldberg, H., Gualtieri, V., Gray, R., Jaffe, J., Kaplan, R., Polse, S., Ross, S., Skaist, L., Treible, D., Vatz, A. and Wallack, H.: Improved control of bulky prostate carcinoma with sequential estrogen and radiation therapy. Int. J. Rad. Oncol. Biol. Physiol., 10: 971, 1984.
12. Pilepich, M. V., Sause, W. T., Shipley, W. U., Krall, J. M., Lawton, C. A., Grignon, D., Al-Sarraf, M., Abrams, R. A., Caplan, R., John, M. J., Rotman, M., Cox, J. D., Doggett, R. L. and Rubin, P.: Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group. Urology, 45: 616, 1995.
13. Bolla, M., Gonzalez, D., Warde, P., Dubois, J. B., Mirimanoff, R. O., Storme, G., Bernier, J., Kuten, A., Sternberg, C., Gil, T., Collette, L. and Pierart, M.: Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin. New Engl. J. Med., 337: 295, 1997.
14. Pilepich, M. V., Caplan, R., Byhardt, R. W., Lawton, C. A., Gallagher, M. J., Mesic, J. B., Hanks, G. E., Coughlin, C. T., Porter, A., Shipley, W. U. and Grignon, D.: Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31. J. Clin. Oncol., 15: 1013, 1997.
15. Zagars, G. K., Pollack, A. and von Eschenbach, A. C.: Management of unfavorable locoregional prostate carcinoma with radiation and androgen ablation. Cancer, 80: 764, 1997.
16. Bagshaw, M. A., Kaplan, I. D. and Cox, R. C.: Prostate cancer. Radiation therapy for localized disease. Cancer, 71: 939, 1993.
17. Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I. and Walsh, P. C.: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol., 150: 110, 1993.
18. Kupelian, P. A., Katcher, J., Levin, H. S. and Klein, E. A.: Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int. J. Rad. Oncol. Biol. Physiol., 37: 1043, 1997.
19. Oesterling, J. E., Chan, D. W., Epstein, J. I., Kimball, A. W., Jr., Bruzek, D. J., Rock, R. C., Brendler, C. B. and Walsh, P. C.: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J. Urol., 139: 766, 1988.
20. Zattoni, F., Piazza, R., Vianello, R., Garbeglio, A. and Pagano, F.: Preoperative and postoperative evaluation of prostate-specific antigen in localized prostatic cancer treated by radical prostatectomy. Eur. Urol., suppl., 21: 99, 1992.